Brand new: Blackmores confirms new CEO, Grape King Bio’s probiotics market strategy, and Korean Ginseng Corp’s focus in China

By Tingmin Koe contact

- Last updated on GMT

Alastair Symington is appointed the new CEO of Blackmores. ©Linkedin
Alastair Symington is appointed the new CEO of Blackmores. ©Linkedin

Related tags: Brands, Blackmores, Ginseng, Australia, China, Taiwan

From the appointment of the new Blackmores CEO, to Taiwanese health food leader Grape King Bio’s probiotics market strategy, and Korean Ginseng Corp’s focus in China, we bring you the latest commercial updates from well-known supplement brands in APAC.
Blackmores’ new CEO: Coty top exec with China experience to take the helm

Blackmores has confirmed Alastair Symington​, one of the top executives from beauty and cosmetics brand Coty, as its new CEO and MD.

Symington, the SVP of consumer beauty at Coty, is currently based in Dubai, overseeing five key regions, namely Asia, Latin America, the Middle East, Africa, and Australia.

With more than 23 years of consumer goods experience in beauty, health, and grooming sectors, he previously worked for other MNCs such as Nestle, Gillette, and P&G.

Step-by-step approach to health benefits crucial for success in China’s probiotics market - Grape King Bio

Taiwan's health food manufacturer Grape King Bio has outlined its plans for China’s probiotics markets, focusing first on products for improving gut health, the immune system, weight management, female and infant health before launching its second and third wave of products.

Specialising in probiotics and Hericium erinaceus – also known as lion’s mane, the Taiwanese health food firm said it would take a step-by-step approach in China, with an initial focus on commonly seen health demands.

Speaking to NutraIngredients-Asia​ at the HI / FI China exhibition held in Shanghai, chairman Dr Andrew Tseng and executive director of the R&D division Dr Hsu Sheng-Chieh revealed that the firm would target the Chinese market​ with the first wave of basic probiotics before launching products for cognitive and oral health.  

Hallyu-influenced health: Korean red ginseng firm targets trendy packaging and female-focused products for China

Korean red ginseng giant Korea Ginseng Corp is looking to further grow its China business​ by bringing tradition to the younger generation of consumers with trendy packaging designs, and developing products specifically targeting the female market.

The company was originally established in 1899 in Korea as a public, government-owned establishment, and looks to expand the reach of red ginseng, and which it has focused on throughout its 120 years of history.

“Our products are available in over 40 countries, but we focus our factories and R&D in Korea and China,”​ Korea Ginseng Corp Director of Strategy, Raw Materials and B2B Yao Ying told FoodNavigator-Asia​ at the recent Fi Asia-China show in Shanghai.

Probiotics for bone health: Asahi launches Japan's first FFC probiotic supplement to improve bone density

Asahi Calpis Wellness, the functional ingredient arm of Asahi Group, has launched a new probiotic tablet supplement that claims to help increase bone density.

The new product is said to be the first Foods with Functional Claims (FFC)​ that provides this particular function in Japan.

Targeted at the elderly consumer group, the product contains 3.4bn units of probiotic strain Bacillus subtilis​C-3102 as the functional component, as it found out that there might be a link between intestinal bacteria and bone metabolism.

MGC Pharma and RMIT develop the 'Google of medicinal cannabis' to support R&D and NPD

Aussie CBD firm MGC Pharmaceuticals and the Royal Melbourne Institute of Technology (RMIT) have recently completed the first stage of development of the digital interface for their database on medicinal cannabis.

The interface, which is both web- and mobile-based, will provide access to the International Library of Cannabinoids (ILC), allowing manufacturers, researchers and doctors to search for relevant information.

Nicknamed the "Google of medicinal cannabis"​ ​by MGC's co-founder Roby Zomer, the ILC contains detailed information from clinical research on different cannabinoid sequences and their potential therapeutic uses.

Related news

Show more

Follow us

Featured Events

View more

Products

View more

Webinars